- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.09. | Universal Ibogaine Inc: Universal Ibogaine board lists five directors | 15 | Stockwatch | ||
| 23.09. | Universal Ibogaine Inc.: Universal Ibogaine Announces Board Changes | 3 | TheNewswire | ||
| 15.09. | Universal Ibogaine Inc: Universal Ibogaine shareholders vote down two matters | 4 | Stockwatch | ||
| 15.09. | Universal Ibogaine Inc.: Universal Ibogaine Announces Results of the Annual Meeting of Shareholders | 15 | TheNewswire | ||
| 05.09. | Universal Ibogaine Inc. provides update on intent to file Clinical Trial Application with Health Canada and confirms securing of Ibogaine drug supply | 17 | TheNewswire | ||
| UNIVERSAL IBOGAINE Aktie jetzt für 0€ handeln | |||||
| 04.09. | Universal Ibogaine Inc: Universal Ibogaine adds Killebrew, Wagner as directors | 13 | Stockwatch | ||
| 03.09. | Universal Ibogaine Inc.: Universal Ibogaine advises of appointment of two new Board Members | 4 | TheNewswire | ||
| 17.07. | Universal Ibogaine Inc: Universal Ibogaine CFO Leavens resigns | 10 | Stockwatch | ||
| 17.07. | Universal Ibogaine announces CFO departure | 13 | Seeking Alpha | ||
| 17.07. | Universal Ibogaine Inc.: Universal Ibogaine advises of departure of CFO | 3 | TheNewswire | ||
| 08.07. | Universal Ibogaine Inc: Universal Ibogaine director Cranwill resigns | 14 | Stockwatch | ||
| 08.07. | Universal Ibogaine Inc.: Universal Ibogaine Advises of Debt Settlement with CEO and Resignation of a Member of its Board of Directors | 5 | TheNewswire | ||
| 08.07. | Universal Ibogaine Inc: Universal Ibogaine 4,248,000 shares for debt | 2 | Stockwatch | ||
| 10.04. | XFRA JC4: WIEDERAUFNAHME/RESUMPTION | 292 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 04.02. | XFRA JC4: AUSSETZUNG/SUSPENSION | 378 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILUNIVERSAL IBOGAINE... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SANOFI | 83,95 | +1,45 % | BERENBERG stuft SANOFI auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Sanofi auf "Buy" mit einem Kursziel von 110 Euro belassen. Der Pharmakonzern sei auf einem guten Weg, im Jahr 2025 eine Marge... ► Artikel lesen | |
| CANOPY GROWTH | 1,260 | +6,42 % | Canopy Growth Corp (2): Canopy's DOJA facility now a medical cultivation site | ||
| ASTRAZENECA | 145,95 | -0,41 % | Signifikanter Erfolg für Krebsmittel von Astrazeneca und Daiichi Sankyo | DJ Signifikanter Erfolg für Krebsmittel von Astrazeneca und Daiichi Sankyo
Von Adam Whittaker
DOW JONES--Das Krebsmedikament Datroway von Astrazeneca und Daiichi Sankyo hat in einer klinischen... ► Artikel lesen | |
| INNOCAN PHARMA | 11,820 | +2,25 % | InnoCan Pharma: Nasdaq-Rallye startet jetzt?! | ||
| IONIS PHARMACEUTICALS | 61,16 | +1,49 % | Ionis Pharmaceuticals stock maintains Buy rating at TD Cowen on pipeline strength | ||
| HAPPY BELLY FOOD GROUP | 0,910 | -2,15 % | Happy Belly Food Group Inc.: Happy Belly Food Group Announces New Franchise Agreement Signed for Heal Wellness in Barrie, Ontario | Toronto, Ontario--(Newsfile Corp. - October 10, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands... ► Artikel lesen | |
| CSPC PHARMA | 1,064 | +4,57 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - SYH2070 INJECTION (A DOUBLE-STRANDED SMALL INTERFERING RNA DRUG) OBTAINS CLINICAL TRIAL APPROVAL IN THE ... | ||
| ALTIMMUNE | 3,451 | +2,37 % | Altimmune Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) | ||
| CATALYST PHARMACEUTICALS | 18,000 | +2,59 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals | CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
| AVADEL PHARMACEUTICALS | 12,000 | -0,83 % | Avadel Pharmaceuticals plc: Avadel Pharmaceuticals Celebrates Five Years of Driving Growth in Sleep Research Funding | A Media Snippet accompanying this announcement is available by clicking on this link. DUBLIN, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The American Academy of Sleep Medicine Foundation (AASM Foundation)... ► Artikel lesen | |
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc.: Numinus Wellness Announces Change of Auditor | Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative... ► Artikel lesen | |
| ONO PHARMACEUTICAL | 10,100 | +3,06 % | Ono's BMS-partnered EP4 antagonist improves progression-free survival in phase 2 gastric cancer test | ||
| ELANCO ANIMAL HEALTH | 16,964 | -0,33 % | Judge Limits Lawsuit Alleging Elanco Monopolized Pet Medication Market | ||
| IANTHUS CAPITAL | 0,002 | +200,00 % | iAnthus Capital Holdings, Inc.: iAnthus Reports Second Quarter 2025 Financial Results | NEW YORK and TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis... ► Artikel lesen | |
| TERRASCEND | 0,750 | +11,11 % | Terrascend Corp: Terrascend to release Q3 2025 results Nov. 6 |
Das Unternehmen UNIVERSAL IBOGAINE INC kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,001 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu UNIVERSAL IBOGAINE INC finden Sie auf Wallstreet Online.